Safety and Effectiveness of the Akreos Toric Intraocular Lens.
NCT ID: NCT00825513
Last Updated: 2013-03-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
198 participants
INTERVENTIONAL
2009-02-28
2012-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of the Safety & Effectiveness of the Bausch & Lomb AKREOS® TL Intraocular Lens
NCT00838045
Acrysof Toric SN60T3corneal Astigmatism Between 0.75 and 1.00 D.
NCT00542581
Astigmatism Management in Cataract Surgery With the AcrySof Toric Intraocular Lens
NCT01075542
Evaluation of the Safety and Effectiveness of the Akreos MI Five-0 Intraocular Lens.
NCT00804726
Clinical Evaluation of a New Aspheric Intraocular Lens.
NCT00786565
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Akreos Toric
Akreos Toric Intraocular Lens
Akreos Toric IOL
Lens implant following cataract surgery
Akreos Advanced
Akreos Advanced Optics Aspheric Intraocular Lens (Akreos AO)
Akreos Advanced Optics Aspheric Intraocular Lens (Akreos AO)
Lens implant following cataract surgery
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Akreos Toric IOL
Lens implant following cataract surgery
Akreos Advanced Optics Aspheric Intraocular Lens (Akreos AO)
Lens implant following cataract surgery
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Subjects must require a lens power from 15 to 30 diopters.
Exclusion Criteria
* Subjects with corneal pathology potentially affecting topography.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Bausch & Lomb Incorporated
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Gabriele Brenger
Role: STUDY_DIRECTOR
Bausch & Lomb Incorporated
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Dept. of Clinical Sciences/ Ophthalmology Umea University Hospital
Umeå, , Sweden
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
566
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.